These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 30635203

  • 1. Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
    Morales Pérez C, Gomez-Pastrana D, Aragón Fernández C, Pérez Escolano E.
    Arch Bronconeumol (Engl Ed); 2019 Jul; 55(7):388-390. PubMed ID: 30635203
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L.
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    Glasauer S, Altmann D, Hauer B, Brodhun B, Haas W, Perumal N.
    PLoS One; 2019 Nov; 14(6):e0217597. PubMed ID: 31188848
    [Abstract] [Full Text] [Related]

  • 11. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study.
    Becerra MC, Huang CC, Lecca L, Bayona J, Contreras C, Calderon R, Yataco R, Galea J, Zhang Z, Atwood S, Cohen T, Mitnick CD, Farmer P, Murray M.
    BMJ; 2019 Oct 24; 367():l5894. PubMed ID: 31649017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A, Akçalı A, Karatağ O, Koşar S, Değirmenci Y, Akman T.
    Mikrobiyol Bul; 2012 Oct 24; 46(4):689-94. PubMed ID: 23188583
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S.
    BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116
    [Abstract] [Full Text] [Related]

  • 19. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C, Phaonakrop N, Jaresitthikunchai J, Gamngoen R, Tragoolpua K, Intorasoot S, Anukool U, Tharincharoen CS, Phunpae P, Tayapiwatana C, Kasinrerk W, Roytrakul S, Butr-Indr B.
    Arch Microbiol; 2018 Mar 03; 200(2):299-309. PubMed ID: 29119205
    [Abstract] [Full Text] [Related]

  • 20. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J, Leckie G, Tang N, Lampinen J, Szostak M, Abravaya K, Wang H.
    Tuberculosis (Edinb); 2016 Dec 03; 101():137-143. PubMed ID: 27865383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.